Nanomedicines overcome the pharmacokinetic limitations of traditional drug formulations
and have promising prospect in cancer treatment. However, nanomedicine delivery in vivo is …

The uncontrolled release of drugs in conventional drug delivery systems has led to the
introduction of new nanotechnology-based drug delivery systems and the use of targeted …

The folate receptor (FR) is a tumor-associated antigen that can bind with folic acid (FA) and
its conjugates with high affinity and ingests the bound molecules inside the cell via the …

Cancer theranostics represents a strategy that aims at combining diagnosis with therapy
through the simultaneous imaging and targeted delivery of therapeutics to cancer cells …

Ovarian carcinoma (OC) is one of the leading causes of death among gynecologic
malignancies all over the world. It is characterized by high mortality rate because of the lack …

Folate receptor (FR) is highly expressed in many types of human cancers, and it has been
actively studied for developing targeted chemotherapy and diagnostic agents. Tremendous …

Genistein (GEN), a natural isoflavone possesses a wide range of pharmacological
properties and nutraceutical applications. GEN has been studied for its anticancer activity …

Due to the lack of early symptoms and difficulty of accurate diagnosis, ovarian cancer is the
most lethal gynecological cancer faced by women. First-line therapy includes a combination …

Background: Nanomedicine is an emerging therapeutic modality. Nanoparticles (NPs) are
potential vehicles for delivery of anticancer therapeutics. NPs can be designed to facilitate …

The purpose of this study was to develop a buccal paclitaxel delivery system using the
thermosensitive polymer Pluronic F127 (PF127) and the mucoadhesive polymer …